newsfilter
← Latest News
GlobeNewswire·

Baudax Bio Announces Closing of $5 Million Public Offering

MALVERN, Pa., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the "Company" or "Baudax Bio") (NASDAQ:BXRX), a pharmaceutical company focused on innovative products for hospital and related settings, today announced